Anthony Traurig, Author at CannIntelligence

Regulatory brief: Czech Republic passes unique law on psychoactive substances

Written by Anthony Traurig || 7th November 2024 || Regulatory reports |

President Petr Pavel recently signed into law an amendment to the Act on Addictive Substances that regulates “psychomodulating substances”. This short report analyses this new law in detail ...

European recreational cannabis models and commercial opportunities

Written by Anthony Traurig || 4th November 2024 || Regulatory reports |

This report examines the models of recreational cannabis legalisation that are currently being implemented in Europe, their nuances, and the commercial opportunities they may provide ...

CannIntelligence policy tracker

Written by Anthony Traurig || 4th November 2024 || Regulatory databases |

The CannIntelligence policy tracker provides a centralised location to track the most significant global policy reforms in cannabis ...

US regulatory tracker: proposed state laws, October

Written by Anthony Traurig || 24th October 2024 || Regulatory databases |

This tracker allows you to track the most relevant and potentially impactful bills from all US states pertaining to hemp, CBD, medical cannabis, and recreational cannabis that have been hand-selected by our analysts based on our daily bill...

US regulatory tracker: medical and recreational cannabis

Written by Anthony Traurig || 27th September 2024 || Regulatory databases |

The US medical and recreational cannabis tracker provides an overview of state laws regarding medical and recreational cannabis in all 50 states ...

An analysis of intoxicating cannabinoid beverages in the US

Written by Anthony Traurig || 29th January 2024 || Regulatory reports |

This report examines regulatory developments in cannabis consumption and explains why CannIntelligence believes that intoxicating cannabinoid beverages have a bright future in the US ...

A comparative analysis of medical cannabis programmes across the globe

Written by Anthony Traurig || 24th November 2023 || Regulatory reports |

The report allows you to easily compare different aspects of medical cannabis programmes from across the globe ...

A regulatory analysis of cannabis consumption lounges in the US

Written by Anthony Traurig || 21st November 2023 || Regulatory reports |

Many state governments are now offering an alternative to adults who wish to consume cannabis outside of their home. This report examines the regulation of these consumption spaces in states that have legalised recreational cannabis ...

A European country analysis of intoxicating hemp-derived cannabinoids

Written by Anthony Traurig || 17th May 2023 || Regulatory reports |

CannIntelligence has analysed regulations and contacted authorities in the majority of European countries to determine the legality of IHDCs. This report presents our findings ...

2022 US cannabis ballot initiative tracker

Written by Anthony Traurig || 15th November 2022 || Regulatory reports |

This tracker outlines the ballot initiatives in the US that are likely to appear on ballot this November and will be updated periodically to keep the information up to date ...

Luxembourg: CBD and cannabis regulation, July 2022

Written by Anthony Traurig || 20th July 2022 || Regulatory reports |

This report offers a detailed summary of the current regulatory framework in place for CBD, hemp and cannabis in Luxembourg. It covers everything from hemp cultivation and processing, to finished products and extracts, and the country's medical and...

Legal dispute leads to US Ninth Circuit Court ruling delta-8 THC federally legal

Written by Anthony Traurig || 27th May 2022 || News analysis |

Delta-8 THC is federally legal under a plain reading of the 2018 Farm Bill, according to the Ninth Circuit Court of Appeals ...

US FDA sets its sights on delta-8 THC, firing warnings over health claims

Written by Anthony Traurig || 5th May 2022 || News analysis |

The US Food and Drug Administration (FDA) has sent warning letters to five marketers of delta-8 THC products over health claims made by the companies ...

US medical cannabis products: a state-by-state regulatory report

Written by Anthony Traurig || 20th April 2022 || Regulatory reports |

This regulatory report analyses the different approaches taken by states over what restrictions they impose on medical cannabis products that patients can buy ...

Top South Dakota court overturns ballot bid to legalise recreational cannabis

Written by Anthony Traurig || 25th November 2021 || News analysis |

Legal recreational cannabis in South Dakota will have to wait following the state Supreme Court’s controversial decision to invalidate Amendment A, a ballot initiative passed by voters a year ago ...

Regulatory report: cannabis delivery in the US

Written by Anthony Traurig || 29th September 2021 || Regulatory reports |

This regulatory report examines which of the 36 US states that have legalised medical and/or recreational cannabis sales allow for home deliveries of cannabis products ...

Regulatory report: delta-8 THC in the US

Written by Anthony Traurig || 19th May 2021 || Regulatory reports |

Delta-8 THC has emerged as the hottest new cannabinoid in the US market. This report examines federal law on delta-8, notes trends that are happening at state level, and discusses what the future may hold ...

US Customs stands accused of seizing legal hemp – and farm machinery

Written by Anthony Traurig || 16th April 2021 || News analysis |

The US Customs and Border Protection (CBP) agency is wrongly seizing legal hemp and hemp-related shipments – such as farm equipment that it claims constitutes drug paraphernalia – according to two recently-filed lawsuits ...

Regulatory report: financial services for CBD companies in the US

Written by Anthony Traurig || 30th March 2021 || Regulatory reports |

This report addresses the reasons why CBD and cannabis-related businesses in the US have trouble obtaining banking and payment processing services, what they can do, and what might be done to address the problem ...

Governor’s influence questioned after judge blocks cannabis legalisation

Written by Anthony Traurig || 23rd February 2021 || News analysis |

The legalisation of recreational cannabis in South Dakota is in doubt, amidst accusations of political interference after a judge appointed by the state governor ruled the voter-approved amendment unconstitutional ...

Regulatory report: Canada, February 2021

Written by Anthony Traurig || 8th February 2021 || Regulatory reports |

Canada permits the cultivation, production, distribution, and sale of hemp, cannabis, and products derived from them, but only by those licensed to do so by the government. This report offers a detailed overview of the rules ...

CBD product labelling – a US state-by-state analysis

Written by Anthony Traurig || 14th January 2021 || Regulatory reports |

This report details the labelling requirements for CBD products of all US states that have enacted regulations and shows how manufacturers can create a versatile label to satisfy as many states' regulations as possible ...

Montana’s ballot initiative to legalise cannabis faces court challenge

Written by Anthony Traurig || 9th December 2020 || News analysis |

A move to legalise cannabis in the US state of Montana, backed by a substantial majority in last month’s ballot, is under threat from a legal bid to block it ...

Regulatory report: CBD in cosmetics – a US state-by-state report

Written by Anthony Traurig || 2nd December 2020 || Regulatory reports |

Cosmetics have been a mainstay in the CBD market in the US, and there are no signs that is likely to change any time soon. This report offers an overview of the current status of CBD in cosmetics...

Opponents unlikely to derail Arizona recreational cannabis legalisation

Written by Anthony Traurig || 20th November 2020 || News analysis |

Voters in the US states of Arizona, Mississippi, Montana, New Jersey, and South Dakota passed ballot initiatives to legalise adult-use and/or medical cannabis in their states. However, the path from ballot initiative to law is not always clear...

Can state governor overturn voters’ ‘wrong choice’ to legalise cannabis?

Written by Anthony Traurig || 18th November 2020 || News analysis |

Electors in South Dakota – not a traditionally cannabis-friendly state – voted overwhelmingly to legalise both medical and recreational cannabis. The governor doesn't like it – but is there anything she can do to stop it? ...

CBD in dietary supplements: alternative pathways to market under the US FDA

Written by Anthony Traurig || 12th November 2020 || Regulatory reports |

The US Food and Drug Administration (FDA) may be open to allowing CBD as an ingredient in dietary supplements as well as in food and drink products. However, the regulatory pathway is not clear ...

Regulatory report: courses of action for proposed US DEA hemp measures

Written by Anthony Traurig || 4th November 2020 || Regulatory reports |

The US Drug Enforcement Administration (DEA)’s new Interim Federal Rule on hemp has many in the industry concerned. There are potential solutions that could allay many industry fears, and this report outlines a few ...

LATEST ALERTS